<DOC>
	<DOC>NCT01752725</DOC>
	<brief_summary>The aim of the study is the evaluation of the efficiency and safety of the new, CE-certified thermofu-sion and dissection instrument BiCision® in comparison with the long established Ultracision® Har-monic Scalpel(Ethicon)during a laparoscopic supracervical hysterectomy (LASH).</brief_summary>
	<brief_title>Comparison of BiCision® Versus UltraCision® During Laparoscopic Supracervical Hysterectomy (LASH)</brief_title>
	<detailed_description />
	<mesh_term>Uterine Hemorrhage</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<criteria>age &gt; 18 gender: female indication for laparoscopic supracervical hysterectomy with no adnexectomyor other surgery will and the capability to comply the study requirements signed informed consent Invasive malignome in the pelvis Cardiac pacemaker or implanted defibrilator if no informations are available about the compatibility with RF energy Abnormal blood parameters (values less than factor 0.8 or more than 1.25 compared to the values of creatinine and standard hemogram) Abnormal coagulation parameters: PTT &gt; 40 sec. and / or Quick'sValue&lt; 50% (the use of antiplateletsup to a max. of 100mg/d is no exclusion criteria) Inability to understand the purpose of the study status after a laparotomy by a longitudinal incision intraabdominal adhesions (at the beginning of the surgery ≥ 5 sectioning for adhesiolysis) open laparoscopy required different anatomical situations that yields to different surgery requirements conspicuous PAP, cervixmyoma or endometriosis of the rectovaginale space</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>supracervical hysterectomy</keyword>
	<keyword>vessel sealing</keyword>
	<keyword>bipolar electrocoagulation</keyword>
</DOC>